FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.8-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

900000000000489007: Concept inactivation indicator attribute value reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001066017 Concept inactivation indicator attribute value reference set en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001067014 Concept inactivation indicator reference set en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001068016 Concept inactivation indicator attribute value reference set (foundation metadata concept) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


141007 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Concept inactivation indicator reference set Is a Attribute value type true Inferred relationship Some

Members valueId
Amidine disinfectant A component that fails to comply with the current editorial guidance.
Amidine disinfectant adverse reaction A component that fails to comply with the current editorial guidance.
Amidostomum species Ambiguous
Amies agar transport medium specimen collection kit, charcoal A component that fails to comply with the current editorial guidance.
Amies agar transport medium specimen collection kit, no charcoal A component that fails to comply with the current editorial guidance.
Amifampridine A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Amifostine - chemical A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Amifostine 500mg/vial injection A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Amifostine 500mg/vial powder A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Amifostine 500mg/vl powder A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Amikacin - chemical A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Amikacin 100mg/2mL pediatric injection Ambiguous
Amikacin 250mg/mL injection solution vial Ambiguous
Amikacin 500mg/100mL conventional release solution for infusion A component that is no longer current, useful, appropriate or acceptable.
Amikacin 500mg/100mL infusion A component that is no longer current, useful, appropriate or acceptable.
Amikacin 62.5mg/mL injection A component that fails to comply with the current editorial guidance.
Amikacin sulfate 100mg/2mL powder Ambiguous
Amikacin sulfate 1gram/4mL injection A component that fails to comply with the current editorial guidance.
Amikacin sulphate - chemical A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Amiloride and loop diuretic adverse reaction Ambiguous
Amiloride and loop diuretic allergy A component that fails to comply with the current editorial guidance.
Amiloride and thiazide diuretic adverse reaction Ambiguous
Amiloride hydrochloride Erroneous component (foundation metadata concept)
Amiloride hydrochloride Erroneous component (foundation metadata concept)
Amiloride hydrochloride - chemical A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Amiloride hydrochloride 5mg A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Amiloride hydrochloride 5mg/5mL s/f oral solution Ambiguous
Amiloride hydrochloride dihydrate A component that fails to comply with the current editorial guidance.
Amiloride hydrochloride+bumetanide Erroneous component (foundation metadata concept)
Amiloride hydrochloride+cyclopenthiazide A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Amiloride+loop diuretic A component that is no longer current, useful, appropriate or acceptable.
Amiloride+thiazide diuretic A component that is no longer current, useful, appropriate or acceptable.
Aminacrine A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Amino acid chromatography A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Amino acid chromatography A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Amino acid deficiency anemia A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Amino acid deficiency anemia A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Amino acid injection A component that fails to comply with the current editorial guidance.
Amino acid injection Erroneous component (foundation metadata concept)
Amino acid injection solution A component that fails to comply with the current editorial guidance.
Amino acid supplement A component that fails to comply with the current editorial guidance.
Amino acid supplement A component that fails to comply with the current editorial guidance.
Amino acid transport disorder NOS Limited component (foundation metadata concept)
Amino acids 10% injection A component that fails to comply with the current editorial guidance.
Amino acids 10% injection solution 500mL bottle A component that fails to comply with the current editorial guidance.
Amino acids 10% solution A component that fails to comply with the current editorial guidance.
Amino acids 11.4% solution A component that fails to comply with the current editorial guidance.
Amino acids 15% solution A component that fails to comply with the current editorial guidance.
Amino acids 20% injection solution A component that is no longer current, useful, appropriate or acceptable.
Amino acids 3%/glycerin 3% injection solution 1L A component that fails to comply with the current editorial guidance.
Amino acids 5% solution A component that fails to comply with the current editorial guidance.
Amino acids 5.4% solution A component that fails to comply with the current editorial guidance.
Amino acids 6% solution A component that is no longer current, useful, appropriate or acceptable.
Amino acids 6.9% injection solution A component that is no longer current, useful, appropriate or acceptable.
Amino acids 7% solution A component that fails to comply with the current editorial guidance.
Amino acids 8% injection solution A component that is no longer current, useful, appropriate or acceptable.
Amino acids 8% solution A component that fails to comply with the current editorial guidance.
Amino acids 8.5% injection solution A component that is no longer current, useful, appropriate or acceptable.
Amino acids 8.5% solution A component that fails to comply with the current editorial guidance.
Amino acids measurement A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Amino acids measurement, quantitative, urine A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Aminoaciduria A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Aminoacyl-histidine dipeptidase deficiency Ambiguous
Aminoacyl-histidine dipeptidase deficiency Ambiguous
Aminobacter niigateaensis Erroneous component (foundation metadata concept)
Aminobacter species Ambiguous
Aminobenzoic acid lotion A component that fails to comply with the current editorial guidance.
Aminocaproic acid 1.25g/5mL oral syrup A component that is no longer current, useful, appropriate or acceptable.
Aminocaproic acid 250mg/mL injection solution ampule A component that is no longer current, useful, appropriate or acceptable.
Aminocaproic acid poisoning of undetermined intent A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Aminoglutethimide A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Aminoglutethimide - chemical A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Aminoglutethimide overdose of undetermined intent A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Aminoglutethimide poisoning of undetermined intent A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Aminoglycosides [respiratory use] A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Aminoglycosides adverse reaction A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Aminoglycosides overdose A component that is no longer current, useful, appropriate or acceptable.
Aminoglycosides poisoning Ambiguous
Aminophylline - chemical A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Aminophylline 100mg modified release tablet A component that is no longer current, useful, appropriate or acceptable.
Aminophylline 100mg prolonged-release oral tablet A component that is no longer current, useful, appropriate or acceptable.
Aminophylline 105mg/5ml oral liquid A component that fails to comply with the current editorial guidance.
Aminophylline 225mg Erroneous component (foundation metadata concept)
Aminophylline 225mg modified release tablet Erroneous component (foundation metadata concept)
Aminophylline 250mg/10mL injection 20mL ampule A component that fails to comply with the current editorial guidance.
Aminophylline 25mg/mL injection solution 10mL amp A component that is no longer current, useful, appropriate or acceptable.
Aminophylline 25mg/mL injection solution 10mL ampule A component that is no longer current, useful, appropriate or acceptable.
Aminophylline 25mg/mL injection solution 10mL prefilled syringe A component that is no longer current, useful, appropriate or acceptable.
Aminophylline 25mg/mL injection solution 10mL vial A component that fails to comply with the current editorial guidance.
Aminophylline 350mg modified release tablet A component that is no longer current, useful, appropriate or acceptable.
Aminophylline 350mg prolonged-release oral tablet A component that is no longer current, useful, appropriate or acceptable.
Aminophylline hydrate 100mg modified-release tablets A component that is no longer current, useful, appropriate or acceptable.
Aminophylline hydrate 225mg modified-release tablet Erroneous component (foundation metadata concept)
Aminophylline hydrate 350mg modified-release tablet A component that is no longer current, useful, appropriate or acceptable.
Aminophylline hydrous A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Aminophylline m/r tablet A component that fails to comply with the current editorial guidance.
Aminophylline overdose of undetermined intent A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Aminophylline poisoning of undetermined intent A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Aminopterin derivative A component that fails to comply with the current editorial guidance.
Aminosalicylate sodium A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Aminosalicylic acid Ambiguous

Start Previous Page 98 of 1411 Next End


Reference Sets

Reference set descriptor

Back to Start